These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 30425655)

  • 21. Decreased levels of myotonic dystrophy protein kinase (DMPK) and delayed differentiation in human myotonic dystrophy myoblasts.
    Furling D; Lemieux D; Taneja K; Puymirat J
    Neuromuscul Disord; 2001 Nov; 11(8):728-35. PubMed ID: 11595515
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Altered mRNA splicing of the skeletal muscle ryanodine receptor and sarcoplasmic/endoplasmic reticulum Ca2+-ATPase in myotonic dystrophy type 1.
    Kimura T; Nakamori M; Lueck JD; Pouliquin P; Aoike F; Fujimura H; Dirksen RT; Takahashi MP; Dulhunty AF; Sakoda S
    Hum Mol Genet; 2005 Aug; 14(15):2189-200. PubMed ID: 15972723
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recapitulating muscle disease phenotypes with myotonic dystrophy 1 induced pluripotent stem cells: a tool for disease modeling and drug discovery.
    Mondragon-Gonzalez R; Perlingeiro RCR
    Dis Model Mech; 2018 Jul; 11(7):. PubMed ID: 29898953
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in myotonic dystrophy protein kinase levels and muscle development in congenital myotonic dystrophy.
    Furling D; Lam le T; Agbulut O; Butler-Browne GS; Morris GE
    Am J Pathol; 2003 Mar; 162(3):1001-9. PubMed ID: 12598332
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myotonic dystrophy protein kinase (DMPK) and its role in the pathogenesis of myotonic dystrophy 1.
    Kaliman P; Llagostera E
    Cell Signal; 2008 Nov; 20(11):1935-41. PubMed ID: 18583094
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sense and Antisense DMPK RNA Foci Accumulate in DM1 Tissues during Development.
    Michel L; Huguet-Lachon A; Gourdon G
    PLoS One; 2015; 10(9):e0137620. PubMed ID: 26339785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A low absolute number of expanded transcripts is involved in myotonic dystrophy type 1 manifestation in muscle.
    Gudde AE; González-Barriga A; van den Broek WJ; Wieringa B; Wansink DG
    Hum Mol Genet; 2016 Apr; 25(8):1648-62. PubMed ID: 26908607
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Staufen1 impairs stress granule formation in skeletal muscle cells from myotonic dystrophy type 1 patients.
    Ravel-Chapuis A; Klein Gunnewiek A; Bélanger G; Crawford Parks TE; Côté J; Jasmin BJ
    Mol Biol Cell; 2016 Jun; 27(11):1728-39. PubMed ID: 27030674
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Altered mRNA splicing of dystrophin in type 1 myotonic dystrophy.
    Nakamori M; Kimura T; Fujimura H; Takahashi MP; Sakoda S
    Muscle Nerve; 2007 Aug; 36(2):251-7. PubMed ID: 17487865
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A role for PLCβ1 in myotonic dystrophies type 1 and 2.
    Faenza I; Blalock W; Bavelloni A; Schoser B; Fiume R; Pacella S; Piazzi M; D'Angelo A; Cocco L
    FASEB J; 2012 Jul; 26(7):3042-8. PubMed ID: 22459146
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loss of the muscle-specific chloride channel in type 1 myotonic dystrophy due to misregulated alternative splicing.
    Charlet-B N; Savkur RS; Singh G; Philips AV; Grice EA; Cooper TA
    Mol Cell; 2002 Jul; 10(1):45-53. PubMed ID: 12150906
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Furamidine Rescues Myotonic Dystrophy Type I Associated Mis-Splicing through Multiple Mechanisms.
    Jenquin JR; Coonrod LA; Silverglate QA; Pellitier NA; Hale MA; Xia G; Nakamori M; Berglund JA
    ACS Chem Biol; 2018 Sep; 13(9):2708-2718. PubMed ID: 30118588
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myotonic dystrophy type 1 patient-derived iPSCs for the investigation of CTG repeat instability.
    Ueki J; Nakamori M; Nakamura M; Nishikawa M; Yoshida Y; Tanaka A; Morizane A; Kamon M; Araki T; Takahashi MP; Watanabe A; Inagaki N; Sakurai H
    Sci Rep; 2017 Feb; 7():42522. PubMed ID: 28211918
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination Treatment of Erythromycin and Furamidine Provides Additive and Synergistic Rescue of Mis-Splicing in Myotonic Dystrophy Type 1 Models.
    Jenquin JR; Yang H; Huigens RW; Nakamori M; Berglund JA
    ACS Pharmacol Transl Sci; 2019 Aug; 2(4):247-263. PubMed ID: 31485578
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Abnormal nuclear aggregation and myotube degeneration in myotonic dystrophy type 1.
    Wang Y; Hao L; Li H; Cleary JD; Tomac MP; Thapa A; Guo X; Zeng D; Wang H; McRae M; Jastrzemski O; Smith-Fassler AM; Xu Y; Xia G
    Neurol Sci; 2019 Jun; 40(6):1255-1265. PubMed ID: 30891637
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Muscleblind localizes to nuclear foci of aberrant RNA in myotonic dystrophy types 1 and 2.
    Mankodi A; Urbinati CR; Yuan QP; Moxley RT; Sansone V; Krym M; Henderson D; Schalling M; Swanson MS; Thornton CA
    Hum Mol Genet; 2001 Sep; 10(19):2165-70. PubMed ID: 11590133
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intrinsic Myogenic Potential of Skeletal Muscle-Derived Pericytes from Patients with Myotonic Dystrophy Type 1.
    Ausems CRM; Raaijmakers RHL; van den Broek WJAA; Willemse M; van Engelen BGM; Wansink DG; van Bokhoven H
    Mol Ther Methods Clin Dev; 2019 Dec; 15():120-132. PubMed ID: 31649961
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myotonic dystrophy 1 in the nervous system: from the clinic to molecular mechanisms.
    de León MB; Cisneros B
    J Neurosci Res; 2008 Jan; 86(1):18-26. PubMed ID: 17549748
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic Potential of AntagomiR-23b for Treating Myotonic Dystrophy.
    Cerro-Herreros E; González-Martínez I; Moreno-Cervera N; Overby S; Pérez-Alonso M; Llamusí B; Artero R
    Mol Ther Nucleic Acids; 2020 Sep; 21():837-849. PubMed ID: 32805487
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular and clinical characteristics of myotonic dystrophy type 1 in koreans.
    Kim SY; Kim JY; Kim GP; Sung JJ; Lim KS; Lee KW; Chae JH; Hong YH; Seong MW; Park SS
    Korean J Lab Med; 2008 Dec; 28(6):483-92. PubMed ID: 19127114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.